Holen Sie sich die Stockscreener-App
0.2681
1.13%
0.003
Handel nachbörslich:
.27
0.0019
+0.71%
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
Director at IGC Pharma (IGC) receives 170,000 shares from RSUs - stocktitan.net
IGC Pharma (IGC) CEO acquires 706,409 shares via equity awards - stocktitan.net
IGC Pharma (IGC) director gains 130K shares from RSU conversions - stocktitan.net
IGC Pharma (IGC) PFO Claudia Grimaldi exercises RSUs and options for more shares - stocktitan.net
IGC Pharma (IGC) price target increased by 10.34% to 4.08 - MSN
IGC.WS (India Globalization Capital) PB Ratio : (As of Apr. 03, 2026) - GuruFocus
IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
How does IGC Pharma Inc perform in inflationary periodsWeekly Gains Report & Technical Buy Zone Confirmations - baoquankhu1.vn
IGC Pharma Launches Strategic National Media Partnership with Ne - gurufocus.com
Aug Breakouts: Should I trade or invest in IGC Pharma Inc2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
IGC Pharma Launches National Media Partnership to Boost Visibility - TipRanks
Signal Recap: What is IGC Pharma Incs valuation compared to sectorQuarterly Portfolio Review & Comprehensive Market Scan Insights - baoquankhu1.vn
Performance Recap: What is IGC Pharma Incs book value per shareMarket Growth Review & Stock Market Timing Techniques - baoquankhu1.vn
IGC Pharma launches 12-part national media campaign with New to The Street to boost investor awareness - TradingView
IGC Pharma (NYSE: IGC) inks 12-part New to The Street deal - stocktitan.net
Aug Shorts: What is IGC Pharma Incs book value per share2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
IGC Pharma Partners with New to The Street for National Media Campaign - National Today
IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness - biospace.com
IGC Pharma heads to Fox Business, Bloomberg in 12-part TV push - stocktitan.net
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates - MSN
IGC Pharma, New to The Street launch 12-part national media partnership - Yahoo Finance
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning - Corsicana Daily Sun
Macro Review: Is IGC Pharma Inc likely to announce a buybackChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
If You Invested $1,000 in IGC Pharma Inc (IGC) - stocktitan.net
Growth Report: Does IGC Pharma Inc stock benefit from AI growthEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Ascendiant Capital maintains IGC Pharma (IGC) buy recommendation - MSN
Fund Flows: Can IGC Pharma Inc ride the EV wave2026 PreEarnings & Daily Technical Stock Forecast Reports - baoquankhu1.vn
India Globalization Capital, Inc.: Fundamental Analysis and Financial Ratings | IGC | US45408X3089 - marketscreener.com
IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 - Hastings Tribune
IGC Achieves Major Milestone in Alzheimer's Trial Amid Financial Loss - GuruFocus
IGC Pharma’s AI-Driven Innovations and Patent Portfolio for Alzheimer’s Disease and Neuropsychiatric Treatments - Minichart
IGC to Showcase AI Platform for Alzheimer's Research at 2026 Con - GuruFocus
IGC Pharma : Annual Transition Report (Form 10-KT) - marketscreener.com
IGC Pharma (IGC) Transition 10-KT: CALMA Phase 2 shows interim agitation improvements - Stock Titan
IGC Pharma to Showcase AI Platform with Alzheimer’s Disease Data Initiative at ADPD 2026 - BioSpace
IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026 - PharmiWeb.com
IGC Pharma to Showcase AI Platform With Alzheimer's Disease Data Initiative at ADPD 2026 - 富途牛牛
CEO Change: What is the Moat Score of IGC Pharma IncMarket Activity Recap & Real-Time Volume Analysis Alerts - baoquankhu1.vn
IGC Pharma (NYSEAMERICAN:IGC) Stock Price Down 1.2% – Time to Sell? - Defense World
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial - Nasdaq
IGC Pharma Secures New Debt Financing for Liquidity - The Globe and Mail
IGC Pharma Secures ~$526K in Financing, Including Default-Convertible Note With Vanquish - TradingView
IGC Pharma (NYSE: IGC) raises cash via discounted note and $219,000 loan - Stock Titan
How IGC Pharma Inc. stock compares to growth peersDollar Strength & Smart Money Movement Tracker - Naître et grandir
EPS Watch: Should value investors consider IGC Pharma IncJuly 2025 Setups & Fast Momentum Entry Tips - baoquankhu1.vn
IGC Pharma, Inc. announced that it has received $0.307 million in funding - marketscreener.com
IGC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
IGC Should I Buy - Intellectia AI
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Suppo - PharmiWeb.com
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research - Nasdaq
Inside IGC Pharma’s AI push to clean up Alzheimer’s data - stocktitan.net
IGC PE Ratio & Valuation, Is IGC Overvalued - Intellectia AI
FOMO Trade: What is the Moat Score of IGC Pharma IncBond Market & Verified Momentum Stock Ideas - baoquankhu1.vn
Trend Report: What is the Moat Score of IGC Pharma IncJuly 2025 Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):